πŸ‡ΊπŸ‡Έ FDA
Patent

US 12313635

Biomarker for thoracic aortic aneurysm

granted A61KA61K31/519A61P

Quick answer

US patent 12313635 (Biomarker for thoracic aortic aneurysm) held by The Regents of the University of California expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/519, A61P, A61P9/00